MARKETVOLUME®

www.MarketVolume.com

OREXIGEN THERAPEUTICS (Stock Symbol: OREX)

OREX- Stock Profile


     
Company Name:OREXIGEN THERAPEUTICS
Stock Ticker (Symbol):OREX
Traded Exchange:NASDAQ Stock Exchange
Average Traded Price:$5.45
Average Daily Traded Volume:2,553,700
Started to Trade on:Friday, July 01, 2011

OREXIGEN THERAPEUTICS Profile

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its lead combination product candidates include Contrave, which has completed Phase III clinical trials; and Empatic that has completed Phase II clinical trials. Contrave is a combination of two drugs, bupropion and naltrexone, in a sustained release formulation (SR). Bupropion is an antidepressant and smoking cessation medication; naltrexone is a treatment for alcohol and opioid addiction. The company's Empatic product candidate is a combination of bupropion SR and zonisamide SR. Zonisamide, in an immediate release formulation for the adjunctive treatment of partial seizures, a form of epilepsy. The company was founded in 2002 and is based in La Jolla, California.

Disclaimer | Privacy © 1997-2013 MarketVolume.com. All Rights Reserved. SV1
Charts
Stocks & ETFs
Indexes
Advance Decline
Knowledge Base
Trading Systems
News

© 1997-2014 www.MarketVolume.com. All Rights Reserved.